Hakan Cetin
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Implementation of specialised care improves survival in patients with amyotrophic lateral sclerosis.
Implementation of specialised care improves survival in patients with amyotrophic lateral sclerosis.
Journal: Neurological research and practice
Published: May 19, 2026
SOD1 Variants in Patients With Amyotrophic Lateral Sclerosis in Central Eastern Europe: From Genetic Testing to SOD1 Targeted Therapy.
Journal: European journal of neurology
Published: April 01, 2026
ALS motor phenotypes: a revised 'OPM' classification.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: March 17, 2026
Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.
Journal: Journal of clinical medicine
Published: January 26, 2026
Demographic, clinical and genetic characteristics of patients with amyotrophic lateral sclerosis from two specialised centres in Austria.
Journal: Journal of neurology
Published: November 17, 2025
Diagnostic performance and safety of the edrophonium test in myasthenia gravis: a retrospective case-control study.
Journal: Neurological research and practice
Published: October 31, 2025
Dermatomyositis masking late onset Pompe disease in a patient with proximal muscle weakness.
Journal: Journal of neuromuscular diseases
Published: October 22, 2025
A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis.
Journal: Therapeutic advances in neurological disorders
Published: September 09, 2025
AlphaMissense prediction for the evaluation of missense variants in the diagnostic setting of neuromuscular disorders.
Journal: Journal of neuromuscular diseases
Published: September 05, 2025
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry.
Journal: Brain : a journal of neurology
Published: September 01, 2025
Efficacy and safety of risdiplam in adults with 5q-associated spinal muscular atrophy: a nationwide observational cohort study in Austria.
Journal: EClinicalMedicine
Published: July 01, 2025
Last Updated: 09/26/2026